Arg128
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Mono-methylation Site Page: > Arg128  -  TAFII31 (rat)

Site Information
CLTAPNYrLKSLQKK   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 13247080

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:
adrenal cancer ( 1 , 2 , 3 ) , pheochromocytoma ( 1 , 2 , 3 )
Relevant cell line - cell type - tissue:

References 

1

Zhou J (2009) CST Curation Set: 6814; Year: 2009; Biosample/Treatment: cell line, PC-12/untreated; Disease: pheochromocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

2

Zhou J (2009) CST Curation Set: 6816; Year: 2009; Biosample/Treatment: cell line, PC-12/NGF; Disease: pheochromocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

3

Zhou J (2009) CST Curation Set: 6815; Year: 2009; Biosample/Treatment: cell line, PC-12/NGF; Disease: pheochromocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info